About

Dr. Sarah P. Psutka is a leading urologic oncologist and researcher whose work sits at the intersection of minimally invasive surgery, artificial intelligence, and health equity. Her primary research areas include robotic-assisted surgery for renal cell carcinoma and testicular cancer, as well as the use of AI to predict surgical outcomes. Among her most impactful contributions is a 2022 systematic review and meta-analysis on robotic-assisted radical nephrectomy with inferior vena cava thrombectomy, which has garnered 51 citations and helped establish the safety and feasibility of this complex procedure compared to open surgery. She has also advanced the field of testicular cancer management through systematic reviews of robot-assisted retroperitoneal lymph node dissection (R-RPLND), with a 2023 study accumulating 31 citations. Demonstrating her forward-looking approach, Dr. Psutka has pioneered the use of artificial intelligence to assess preoperative body composition from CT scans, correlating these measures with complications after radical cystectomy. Her work on racial disparities in surgical margins for renal cancer and her surveys on single-port robotic training further underscore her commitment to improving both surgical technique and equitable patient outcomes.

Research Focus

Key Achievements

5
H-Index
7
Papers
134
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
A Decade of Robotic-Assisted Radical Nephrectomy with Inferior Vena Cava Thrombectomy: A Systematic Review and Meta-Analysis of Perioperative Outcomes
51 citations · 2022
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 80
🏛 Institutions: University of Washington, Mayo Clinic in Arizona, Fred Hutch Cancer Center, John H. Stroger, Jr. Hospital of Cook County

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago